Briefly, gD carries the scFv to HER2 in place of aa 6 to 38 for cancer retargeting, while gH carries the 20-aa-long GCN4 peptide, derived from a yeast transcription factor (recombinant R-213). This evidence concerns the gene ERBB2 and cancer.